We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva and Ivax Report Revenue Growth in Second Quarter 2005
Teva and Ivax Report Revenue Growth in Second Quarter 2005
August 1, 2005
Generic powerhouse Teva Pharmaceutical reported $241 million in net income and $1.23 billion in net sales during the second quarter, an increase of 5 percent and 4 percent respectively over the same period last year, according to the firm’s earnings report.